Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05505500
Other study ID # HUM00208148
Secondary ID 5UG3FD007308-02
Status Recruiting
Phase
First received
Last updated
Start date April 18, 2022
Est. completion date April 2026

Study information

Verified date September 2023
Source University of Michigan
Contact Tina Creguer
Phone 734-936-3590
Email tcreguer@umich.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Researchers from the University of Michigan and Northwestern University are studying people's experiences with swelling caused by Nephrotic Syndrome. Interviews with patients (child and adult) and parents of young children will be conducted. The information collected from the interviews will be used to develop a survey to use when testing new medications for Nephrotic Syndrome. Please consider participating in a 1-hour long interview with the Prepare-NS research study to discuss children and adults experiences with swelling.


Description:

This registration includes concept elicitation, analysis and creation of complementary survey measures focused on edema/fluid overload of nephrotic syndrome. The measures to be developed include an Observer Reported Outcome (ObsRO) and Patient Reported Outcome (PRO). The ObsRO and PRO substudies are Institutional Review Board (IRB) approved at release. The researcher's goal is to produce core outcome sets of patient-rated and observer reported Fluid Overload (edema) measures that can be applied across the fluid overload severity continuum, fit to help drug development in this area.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date April 2026
Est. primary completion date April 2026
Accepts healthy volunteers No
Gender All
Age group 2 Years and older
Eligibility Criteria for the Observer Reported Outcomes (ObsRO) cohort of the study: Inclusion Criteria: 1. Parents/guardians must be able to read and understand English; 2. Parents/guardians must be caring for a child (ages 2-11.999) with a medically documented diagnosis of idiopathic (primary) Nephrotic Syndrome (NS) or primary or monogenic NS associated kidney disease. Populations with Primary NS Conditions: Focal segmental glomerulosclerosis (FSGS), Minimal Change Disease (MCD), Immunoglobulin M (IgM) Nephropathy, Membranous Nephropathy (MN), and childhood - onset nephrotic syndrome not biopsied; 3. The child must have a current or history of NS-associated edema within the past 3 months; 4. The child may have native kidney function or may be kidney transplant dependent with a history of post-transplant NS recurrence; 5. Parents/guardians must provide informed consent. Exclusion Criteria: 1. Index case with dialysis dependence throughout the 3-month pre-enrollment period Criteria for the Patient Reported Outcomes (PRO) cohort of the study: Inclusion Criteria: 1. =8 years of age 2. Able to read and understand English 3. Primary (idiopathic) kidney disease that causes NS or monogenic NS associated kidney disease. i. Populations with Primary Nephrotic Syndrome (NS) Conditions include: FSGS, MCD, IgM nephropathy, MN, and childhood - onset nephrotic syndrome not biopsied ii. Kidney disease in the native kidneys or recurrent in kidney transplant 4. Current or history of NS-associated edema within the past 3 months 5. Kidney function with most recent estimated Glomerular Filtration Rate (eGFR) > 25 ml/min/1.73m2 6. Informed Consent: For patients =8 to <18 years of age: a parent or legal guardian provide informed consent and the patient must provide assent. Patients =18 years of age must provide informed consent. Exclusion Criteria: 1. Native kidney disease participant with dialysis dependence during the 3-month pre-enrollment period OR kidney transplant recipient with ongoing dialysis therapy at the time of enrollment. 2. Co-existing significant chronic or severe acute health condition that has the potential to influence how the participant feels or functions as related to fluid overload in NS

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Interview
Concept Elicitation Interviews are used to create tools followed by Cognitive Debrief Interviews that are used to review created tools.

Locations

Country Name City State
United States University of Michigan Ann Arbor Michigan

Sponsors (3)

Lead Sponsor Collaborator
University of Michigan Food and Drug Administration (FDA), Northwestern University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient Reported Impact of Fluid Overload on symptoms and functioning Themes generated through qualitative analysis from semi-structured interviews Interviews are 60 minutes
Primary Observer Reported Impact of Fluid Overload on symptoms and functioning Themes generated through qualitative analysis from semi-structured interviews Interviews are 60 minutes
See also
  Status Clinical Trial Phase
Completed NCT04095143 - Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT05070819 - Atrial Natriuretic Peptide in Assessing Fluid Status N/A
Withdrawn NCT04870073 - Retrograde Autologous Priming and Mannitol for Reducing Hemodilution in Cardiac Surgery Phase 3
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Completed NCT00852514 - The Optimization of Blood Pressure and Fluid Status Control With Eight-Polar Bioelectrical Impedance Analysis Phase 4
Completed NCT00517127 - Crystalloids Versus Colloids During Surgery Phase 4
Not yet recruiting NCT05983549 - Neutral Versus Liberal fLuId In Traumatic Brain Injury: a Randomised Controlled Trial N/A
Completed NCT03929471 - Target Weight Correction and Vascular Stiffness in Hemodialysis Patients N/A
Recruiting NCT06071026 - Hemodynamic Effects of Variations in Net Ultrafiltration Rate During Continuous Renal Replacement Therapy. N/A
Completed NCT02903316 - Predicting Fluid Responsiveness in on Pump Coronary Artery Bypass Graft Using Extra Systoles N/A
Terminated NCT02458157 - Forced Fluid Removal in High Risk Acute Kidney Injury Phase 4
Completed NCT02325856 - Application of Bioimpedance Spectroscopy in Taiwan Dialysis Patients N/A
Completed NCT01628731 - Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease Phase 3
Not yet recruiting NCT05647200 - Optimization of Prime Fluid Strategy to Preserve Microcirculatory Perfusion During Cardiac Surgery With Cardiopulmonary Bypass, Part II N/A
Completed NCT03768752 - Diastolic Dysfunction and Interstitial Lung Edema in Septic Patients
Terminated NCT03553394 - Effects of Restrictive Fluid Strategy on Postoperative Oliguric Pancreatic Surgery Patients N/A
Completed NCT06097923 - Implementation of Fluid Strategies Using Real-time Bioelectrical Analyzer in Surgical Intensive Care Unit (SICU) N/A
Recruiting NCT04215692 - Lung Ultrasound-guided Fluid Therapy in Pediatric Intensive Care Unit Patients N/A
Not yet recruiting NCT03322410 - Hydratation Status at Initiation of Peritoneal Dialysis: Study of the Role of Peritoneal Permeability N/A